Francis Crick Institute, London, UK.
The Royal Marsden Hospital, London, UK.
J Exp Med. 2018 Oct 1;215(10):2477-2479. doi: 10.1084/jem.20181617. Epub 2018 Sep 14.
Chris Boshoff, Senior Vice President of Immuno-Oncology, Translational and Early Development at Pfizer, and colleagues Samra Turajlic and Charles Swanton from the Francis Crick Institute and University College London give us their personal point of view on new insights and future therapeutic approaches for renal cancer.
辉瑞公司免疫肿瘤学、转化和早期研发高级副总裁克里斯·博肖夫(Chris Boshoff)和弗朗西斯·克里克研究所(Francis Crick Institute)及伦敦大学学院的同事萨默拉·图拉利奇(Samra Turajlic)和查尔斯·斯旺顿(Charles Swanton)从个人角度探讨了肾癌的新见解和未来治疗方法。